BIIB | | BIOGEN INC. | Artavanis-Tsakonas Spyridon | EVP, Chief Scientific Officer | Apr 02, 2016 | Option Exercise | $260.54 | 459 | 119,588 | 3,150 | Apr 05, 2016, 05:06 PM |
BIIB | | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 23, 2016 | Option Exercise | $258.99 | 48 | 12,432 | 2,549 | Feb 25, 2016, 05:07 PM |
BIIB | | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 12, 2016 | Option Exercise | $247.22 | 352 | 87,021 | 2,452 | Feb 17, 2016, 05:54 PM |
BIIB | | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Apr 02, 2015 | Option Exercise | $412.44 | 460 | 189,722 | 1,674 | Apr 03, 2015, 04:24 PM |
BIIB | | BIOGEN IDEC INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 12, 2015 | Option Exercise | $392.11 | 394 | 154,491 | 1,159 | Feb 17, 2015, 08:50 PM |
BIIB | | BIOGEN IDEC INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Dec 15, 2014 | Sale | $346.50 | 1,981 | 686,417 | 352 | Dec 16, 2014, 04:36 PM |
BIIB | | BIOGEN IDEC INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Apr 02, 2014 | Option Exercise | $309.70 | 433 | 134,100 | 2,244 | Apr 03, 2014, 04:27 PM |
BIIB | | BIOGEN IDEC INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientific Officer | Feb 12, 2014 | Option Exercise | $323.04 | 239 | 77,207 | 1,702 | Feb 14, 2014, 04:45 PM |